The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone.

MLA

Puig, Lluís, et al. “The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone.” Dermatologic Therapy, vol. 2024, Oct. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1155/2024/2351576.

APA

Puig, L., Pérez-Hernández, M., & Liu, X. (2024). The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone. Dermatologic Therapy, 2024, 1–14. https://doi.org/10.1155/2024/2351576

Chicago

Puig, Lluís, M. Pérez-Hernández, and Xiaoming Liu. 2024. “The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone.” Dermatologic Therapy 2024 (October): 1–14. doi:10.1155/2024/2351576.